← Back to Search

Transcatheter Aortic Valve Replacement

HLT Transcatheter Aortic Valve System for Aortic Valve Stenosis (RADIANT CANADA Trial)

N/A
Waitlist Available
Led By Josep Rodés-Cabau, MD
Research Sponsored by HLT Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up throughout the 5 year follow up period
Awards & highlights

RADIANT CANADA Trial Summary

This trial is testing a new system for patients with a severe heart condition who are at high risk for surgery. The goal is to see if it is safe and works well.

RADIANT CANADA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~throughout the 5 year follow up period
This trial's timeline: 3 weeks for screening, Varies for treatment, and throughout the 5 year follow up period for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Primary Endpoint: Mortality at 30 days
Secondary outcome measures
Secondary Performance Endpoint 1: Procedural Device Performance
Secondary Performance Endpoint 2: Post-procedural Valve Performance (Aortic Valve Effective Orifice Area)
Secondary Performance Endpoint 2: Post-procedural Valve Performance (Aortic Valve Gradient)
+2 more

RADIANT CANADA Trial Design

1Treatment groups
Experimental Treatment
Group I: HLT Transcatheter Aortic Valve SystemExperimental Treatment1 Intervention
Transcatheter aortic valve replacement with HLT Transcatheter Aortic Valve System
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
HLT Transcatheter Aortic Valve System
2014
N/A
~20

Find a Location

Who is running the clinical trial?

HLT Inc.Lead Sponsor
5 Previous Clinical Trials
16 Total Patients Enrolled
4 Trials studying Aortic Valve Stenosis
16 Patients Enrolled for Aortic Valve Stenosis
Josep Rodés-Cabau, MDPrincipal InvestigatorInstitut universitaire de cardiologie et de pneumologie de Québec, University Laval
5 Previous Clinical Trials
1,847 Total Patients Enrolled
3 Trials studying Aortic Valve Stenosis
1,212 Patients Enrolled for Aortic Valve Stenosis
Harindra Wijeysundera, MDPrincipal InvestigatorSunnybrook Health Sciences Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an opportunity for individuals to take part in this clinical experiment?

"As per clinicaltrials.gov, this medical trial is not presently recruiting patients. First posted on December 1st 2016, the study was last updated on August 2nd 2022 and currently has no active recruitment efforts. Alternately, there are 161 other trials actively looking for volunteers now."

Answered by AI
Recent research and studies
Circulation: Cardiovascular InterventionsJournal
Transcatheter Aortic Valve Replacement with the HLT Meridian Valve
Rodés-Cabau, Josep, Mathew R. Williams, Harindra C. Wijeysundera, Dean J. Kereiakes, Jean-Michel Paradis, Cezar Staniloae, Muhamed Saric, Sam Radhakrishnan, Robert F. Wilson, and Spencer H. Kubo. 2019. “Transcatheter Aortic Valve Replacement with the HLT Meridian Valve”. Circulation: Cardiovascular Interventions. Ovid Technologies (Wolters Kluwer Health). doi:10.1161/circinterventions.119.008053.
clinicaltrials.govStudy
Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve Feasibility Trial CANADA
2016. "Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve Feasibility Trial CANADA". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02838680.
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top